SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-16-017787
Filing Date
2016-10-28
Accepted
2016-10-28 17:01:32
Documents
54
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0916_actiniumpharma.htm 10-Q 623441
2 CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL AND ACC f10q0916ex31i_actiniumpharma.htm EX-31.1 14580
3 CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL AND ACC f10q0916ex32i_actiniumpharma.htm EX-32.1 7783
  Complete submission text file 0001213900-16-017787.txt   3368582

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE atnm-20160930.xml EX-101.INS 532590
5 XBRL SCHEMA FILE atnm-20160930.xsd EX-101.SCH 42386
6 XBRL CALCULATION FILE atnm-20160930_cal.xml EX-101.CAL 26796
7 XBRL DEFINITION FILE atnm-20160930_def.xml EX-101.DEF 134985
8 XBRL LABEL FILE atnm-20160930_lab.xml EX-101.LAB 380007
9 XBRL PRESENTATION FILE atnm-20160930_pre.xml EX-101.PRE 240045
Mailing Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016
Business Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016 646-677-3875
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

IRS No.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36374 | Film No.: 161959321
SIC: 2834 Pharmaceutical Preparations